跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
信必可都保 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Budesonide and Formoterol Fumarate Powder for Inhalation(II)
Approved
化学药品
Budesonide and Formoterol Fumarate Powder for Inhalation(II)
ASTRAZENECA AB
🇨🇳 National Medical Products Administration
Approval Date
Feb 23, 2024
Approval ID
8ZY4gHAftbf
Company
ASTRAZENECA AB
Type
化学药品
Approval Details
Approval Id
8ZY4gHAftbf
Approval Number
国药准字HJ20140457
Generic Name
布地奈德福莫特罗吸入粉雾剂(Ⅱ)
Generic Name En
Budesonide and Formoterol Fumarate Powder for Inhalation(II)
Trade Name
信必可都保
Drug Type
化学药品
Dosage Form
吸入粉雾剂
Strength
每支120吸,每吸含布地奈德160μg和富马酸福莫特罗4.5μg
Reg Date
2024-02-23
Expired Date
2029-02-22
Company Name
ASTRAZENECA AB
Production Company Name
ASTRAZENECA AB
Company Detail Path
/organization/astrazeneca-ab
Production Company Detail Path
/organization/astrazeneca-ab
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Feb 23, 2024
Approval ID
8ZY4gHAftbf
Type
化学药品
Back to NMPA Approvals